Public Gatekeepers, Private Returns

The commercial incentives shaping EU medical device conformity assessment Key Messages The EU’s decentralized conformity assessment model relies on independent, mostly commercial notified bodies to provide regulatory oversight while supporting innovation and timely market access. Because notified body certification is mandatory for most medical devices, this model creates a captive market in which manufacturers, particularly […]

When One QA/RA Hire Has to Be an Entire Department

When One QA/RA Hire Has to Be an Entire Department Why Quality and Regulatory work is fundamentally different in a medtech startup. Key messages A startup’s first QA/RA hire is not the same role as QA or RA positions found in most large medtech organizations. Large organizations separate Regulatory Affairs and Quality Assurance into specialized […]

Your Competitor Launches Faster. Their Notified Body May Be the Reason.

Your Competitor Launches Faster. Their Notified Body May Be the Reason. Why MedTech Leaders Should Benchmark Their Regulatory Strategy and Notified Body Performance Key messages: There are significant differences between how notified bodies interpret the EU-MDR rules related to product changes and new product introductions. For Class IIa and IIb (non-implantable) devices a full technical […]

Dating Your Future Notified Body: Questions to Ask Before Committing

Dating Your Future Notified Body: Questions to Ask Before Committing Signing up with a notified body is a bit like marrying and moving in with someone after only a couple of dates on neutral territory. You hope it is the start of a long and fruitful relationship, but you have only very limited information about […]

Beyond First Clearance: The Hidden Cost of Product Changes in the EU and US

Beyond First Clearance: The Hidden Cost of Product Changes in the EU and US We often focus on the first clearance. Getting market access for your product in either the EU or the US is a major hurdle and milestone, and a cause for much celebration. However, this should hopefully be the start of a […]

Eliminate the Cliffs in Your QMS

Eliminate the Cliffs in Your QMS How to design processes that scale with risk instead of creating compliance bottlenecks In last week’s post, we discussed the effect of regulatory cliffs—step changes in regulatory burden—and how they can distort innovation. In particular, under the 510(k) process in the US, there is a strong incentive to downplay […]

Why Regulatory Cliffs Distort Innovation

Why Regulatory Cliffs Distort Innovation How step changes in regulatory burden drive design decisions instead of patient needs In principle, most medical device regulatory frameworks are risk-based. This means that as the risks of a device increase, the amount of required evidence and thus the regulatory burden, should also increase. This sounds reasonable in theory. […]

FDA PCCPs: Do they really help you move faster, or just add complexity?

FDA PCCPs: Do they really help you move faster, or just add complexity? If you’re developing a software medical device (particularly one incorporating AI/ML) you’ve likely heard that Predefined Change Control Plans (PCCPs) are the answer to one of the biggest frustrations in US regulation: the need to submit a new 510(k) for every meaningful […]

This website uses cookies to ensure you get the best experience on our website. If you want to get more information about this, please view our privacy policy page.